Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 infection as a potential risk factor for the development of cancer

11 Sept 2023

Abstract excerpt

The COVID-19 pandemic has a significant impact on public health and the estimated number of excess deaths may be more than three times higher than documented in official statistics. Numerous studies have shown an increased risk of severe COVID-19 and death in patients with cancer. In addition, the role of SARS-CoV-2 as a potential risk factor for the development of cancer has been considered. Therefore, in this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to COVID-19 and healthcare impacts
Share to COVID-19 Clinical Research Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37753372
DOI: 10.3389/fmolb.2023.1260776

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 infection as a potential risk factor for the development of cancerPMID 37753372Read ↗

New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?Semantic proximity Read ↗

SARS‐CoV‐2 infection and cancerSemantic proximity Read ↗

Deciphering the Relationship between SARS-CoV-2 and CancerSemantic proximity Read ↗

Covid-19 And Cancer: Insights Into Their Association And Influence On Genetic And Epigenetic LandscapeSemantic proximity Read ↗

Possible cancer-causing capacity of COVID-19: Is SARS-CoV-2 an oncogenic agent?Semantic proximity Read ↗

COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario.Semantic proximity Read ↗

Safeguarding COVID-19 and cancer management: drug design and therapeutic approachSemantic proximity Read ↗

Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer PatientsSemantic proximity Read ↗

Cancer related-genes enriched in peripheral blood mononuclear cells (PBMCs) of COVID-19 patients. a bioinformatics studySemantic proximity Read ↗

Persistent SARS-CoV-2 infection and the risk for cancerSemantic proximity Read ↗

Possible role of autophagy induced by COVID-19 in cancer progression, chemo-resistance, and tumor recurrenceSemantic proximity Read ↗

Viral oncogenesis in cancer: from mechanisms to therapeuticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.